MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ehjopen/oead109

Медицинская библиотека · European heart journal open · 2023

Blood pressure control in hypertensive sleep apnoea patients of the European Sleep Apnea Database cohort - effects of positive airway pressure and antihypertensive medication.

Svedmyr Sven, Hedner Jan, Bailly Sebastien, Fanfulla Francesco, Hein Holger, Lombardi Carolina, Ludka Ondrej, Mihaicuta Stefan, Parati Gianfranco, Pataka Athanasia, Schiza Sophia, Tasbakan Sezai, Testelmans Dries, Zou Ding, Grote Ludger, European Sleep Apnea Database (ESADA) study group

СтатьяПеревод пока не подготовлен

Аннотация

AIMS: We analysed longitudinal blood pressure (BP) data from hypertensive obstructive sleep apnoea (OSA) patients in the European Sleep Apnea Database cohort. The study investigated the interaction between positive airway pressure (PAP)-induced BP change and antihypertensive treatment (AHT).

METHODS AND

RESULTS

Hypertensive patients with AHT [monotherapy/dual therapy n = 1283/652, mean age 59.6 ± 10.7/60.6 ± 10.3 years, body mass index (BMI) 34.2 ± 6.5/34.8 ± 7.0 kg/m2, apnoea-hypopnoea index 46 ± 25/46 ± 24 n/h, proportion female 29/26%, respectively] started PAP treatment. Office BP at baseline and 2- to 36-month follow-up were assessed. The interaction between AHT drug classes and PAP on BP was quantified and the influences of age, gender, BMI, co-morbidities, BP at baseline, and study site were evaluated. Following PAP treatment (daily usage, 5.6 ± 1.6/5.7 ± 1.9 h/day), systolic BP was reduced by -3.9 ± 15.5/-2.8 ± 17.7 mmHg in mono/dual AHT and diastolic BP by -3.0 ± 9.8/-2.7 ± 10.8 mmHg, respectively, all P < 0.0001. Systolic and diastolic BP control was improved following PAP treatment (38/35% to 54/46% and 67/67% to 79/74%, mono/dual AHT, respectively). PAP treatment duration predicted a larger BP improvement in the monotherapy group. Intake of renin-angiotensin blockers [angiotensin converting enzyme inhibitor (ACEI)/angiotensin receptor blocker (ARB)] alone or in any AHT combination was associated with better BP control. The AHT-dependent BP improvement was independent of confounders.

CONCLUSION

In this pan-European OSA patient cohort, BP control improved following initiation of PAP. Longer PAP treatment duration, was associated with a favourable effect on BP. Our study suggests that ACEI/ARB, alone or in combination with other drug classes, provides a particularly strong reduction of BP and better BP control when combined with PAP in OSA.

Для цитирования: Svedmyr Sven, Hedner Jan, Bailly Sebastien, Fanfulla Francesco, Hein Holger, Lombardi Carolina, Ludka Ondrej, Mihaicuta Stefan, Parati Gianfranco, Pataka Athanasia, Schiza Sophia, Tasbakan Sezai, Testelmans Dries, Zou Ding, Grote Ludger, European Sleep Apnea Database (ESADA) study group. Blood pressure control in hypertensive sleep apnoea patients of the European Sleep Apnea Database cohort - effects of positive airway pressure and antihypertensive medication.. European heart journal open. 2023. DOI: 10.1093/ehjopen/oead109.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.